Completed PHASE3 INTERVENTIONAL NCT00439283

Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis

Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis: Comparison of Infusion Every 6 Weeks Versus Infusion on Demand

Sponsor: Association de Recherche Clinique en Rhumatologie

Conditions Ankylosing Spondylitis

Interventions infliximab methotrexate

Updated 6 times since 2017 Last updated: Feb 26, 2007 Started: Apr 30, 2003 Completion: Dec 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00439283, this PHASE3 trial focuses on Ankylosing Spondylitis and remains completed. Sponsored by Association de Recherche Clinique en Rhumatologie, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Association de Recherche Clinique en Rhumatologie

Data source: Association de Recherche Clinique en Rhumatologie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Besançon, France , Bobigny, France , Bordeaux, France , Boulogne-Billancourt, France , Brest, France , Caen, France , Corbeil-Essonnes, France , Créteil, France , Dijon, France and 20 more locations